Case Study: From speed to cost efficiency – Effectively transforming MES along the business needs

Session

From speed to cost efficiency – Effectively transforming MES along the business needs

Case Study

Thursday, March 21

09:45 AM - 10:15 AM

Live in Everett

Less Details

The presentation will address the impact of shifting business requirements on MES by illustrating it with the latest developments at Pfizer. While having a long history of MES, including legacy MES as well as 2nd generation MES in different sites, COVID-19 and the newly changed business needs created a situation that triggered massive changes. The increased urgency of delivery led to higher speed in manufacturing, important changes of processes, e.g. with regard to the batch records tracking, but also of the mentality in the organization. Currently, the new speed and many improvements are used to again answer to the changing business needs: by focusing on cost awareness, the effectiveness is reflected in better quantifying and accelerating deployments, thus opening new possibilities for MES. In this session, you will learn

How to effectively align MES with business requirements
How to quickly adapt and improve processes
What the main technical challenges related to a fast change are and how they can be addressed
What are the long-term benefits of increased efficiency and speed

Speaker

Mathias Duhamel

Senior Manager, Manufacturing Execution Solutions, Pfizer, Inc.

Mathias Duhamel is Senior Manager Manufacturing Execution Systems at Pfizer where he has been working in different positions for more than 8 years, among others being responsible for the MES deployment, Batch Records for different products, and as project engineer. He holds a Master of Science (MSc) in Bioscience Engineering from the Ghent University.

Join Mathias Duhamel
Book Now!

Company

Pfizer, Inc.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.

Get Agenda

Book Now